Westlake's (WLK) action builds on the company's commitment to contributing to a more sustainable future through continual development of its own manufacturing as well as strategic investments.
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.